Haoxi Health Technology Ltd. (HAO) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$2.95

From 52W high−99.93%

Volume19877.00

Market cap$1.75M

P/E (TTM)—

P/S (TTM)0.0x

Div yield—

Key dataSep 18, 2026

Open

$2.95

From 52W high

−99.93%

Volume

19877.00

Market cap

$1.75M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.8x

P/E (TTM)

—

RSI (14)

41.2

MomentumView details →

1D Return

−2.05%

YTD Return

−99.90%

SummaryUpdated Dec 1, 2025

Haoxi Health Technology Limited (NASDAQ:HAO) is a Chinese digital marketing company founded in 2018 and headquartered in Beijing. The company went public on January 26, 2024, through an initial public offering on the NASDAQ exchange. Haoxi specializes in providing online marketing solutions primarily to healthcare industry clients in China, leveraging popular social media and short video platforms to help advertisers reach and engage consumers. Despite being a relatively young company, Haoxi has established itself as a focused player in China's rapidly growing digital advertising ecosystem, particularly in the healthcare vertical.

Ask drillr about Haoxi Health Technology Ltd. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

2.8x

EV/Sales

−0.1x

P/S (TTM)

0.0x

P/B (TTM)

0.1x

ProfitabilityView details →

Gross Margin

4.79%

Net Margin

−6.50%

EBITDA Margin

−2.87%

ROE (TTM)

−17.37%

ROA (TTM)

−13.42%

Asset Turnover

2.02x

GrowthView details →

Revenue YoY

−12.85%

EPS YoY

—

FCF YoY

−0.78%

Revenue CAGR 3Y

+26.63%

EPS CAGR 3Y

+310.49%

EBITDA YoY

—

MomentumView details →

1D Return

−2.05%

YTD Return

−99.90%

1Y Return

−99.91%

RSI (14)

41.2

vs 50D SMA

−20.51%

vs 200D SMA

−99.78%

Capital & dividendView details →

Debt/Equity

0.10x

Current Ratio

3.45x

Quick Ratio

3.45x

Div Yield

—

Div Rate

—

Div Growth 1Y

−98.70%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

91.65M

Net Income (TTM)

−2.47M

Op. CF (TTM)

−6.67M

Latest newsMore news →

Haoxi Health Technology Limited announced a 1-for-20 reverse share split of its Class A and Class B ordinary shares, effective for trading on Nasdaq from August 14, 2026.39d ago

Univest Securities announced the closing of a $4 million registered direct offering for its client Haoxi Health Technology Ltd.69d ago

Similar companies

Direct Digital Holdings, Inc.DRCT VS Media Holdings Limited Class A Ordinary SharesVSME Cheer Holding, Inc.CHR Fast Track GroupFTRK Kustom Entertainment, Inc.KUST Star Fashion Culture Holdings LimitedSTFS Find similar companies →

Latest newsMore news →

Haoxi Health Technology Limited announced a 1-for-20 reverse share split of its Class A and Class B ordinary shares, effective for trading on Nasdaq from August 14, 2026.39d ago Univest Securities announced the closing of a $4 million registered direct offering for its client Haoxi Health Technology Ltd.69d ago